Advertisement · 728 × 90

Posts by The Lancet

Research in context panel for a paper published in The Lancet entitled 'Non-surgical casting versus surgical reduction for children with severely displaced distal radial fractures (the CRAFFT Study): a multicentre, randomised, controlled non-inferiority trial and economic evaluation'. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.

Research in context panel for a paper published in The Lancet entitled 'Non-surgical casting versus surgical reduction for children with severely displaced distal radial fractures (the CRAFFT Study): a multicentre, randomised, controlled non-inferiority trial and economic evaluation'. Copyright: 2026 The Author(s). Published by Elsevier Ltd. CC BY 4.0.

Distal radial fractures are the most common bony injury in children. They are typically treated by closed reduction under sedation or general anaesthesia.

A study evaluated the clinical & cost-effectiveness of surgical reduction compared with non-surgical casting: spkl.io/63326A48dI

6 hours ago 3 0 1 0
Preview
Abortion: the possibilities of progress Women's bodily autonomy and health, particularly with regard to abortion, are under attack. The politicisation of women's bodies and choices is part of a wider attempt to roll back human rights and fr...

"It is a fundamental right of a woman to decide whether and when she has children, and is central to gender justice."

A new Editorial advocates for women's abortion rights and reproductive health globally: tinyurl.com/2p82xa62

1 day ago 5 4 0 0
Preview
ONE HEALTH SUMMIT - Panel n°1 Science for Innovation and Action Panel 1 – Scientific knowledge for innovation and action: building One Health cooperation for a healthy and prosperous future Round table Moderator: Dr Richard Horton, Editor-in-Chief, The Lancet H.E. Duma Gideon Boko, President of the Republic of Botswana Mr John-Arne Røttingen, Chief Executive of the Wellcome Trust Mr Jozef Síkela, European Commissioner for International Partnerships Mr Khaled El-Enany, Director-General of the United Nations Educational, Scientific and Cultural Organisation (UNESCO) Dr Sania Nishtar, Executive Director of Gavi, the Vaccine Alliance Mr Akihiko Nishio, Vice-President for Development Finance at the World Bank Conclusion Mr Qu Dongyu, Director-General of the Food and Agriculture Organisation of the United Nations (FAO) 🌍 Share ➜ #OnePlanetSummit More about ➜ www.oneplanetsummit.fr/en

Watch the panel on Science for Innovation and Action, moderated by Richard Horton at the International Summit on One Health: tinyurl.com/yjjdv9zw

1 day ago 1 1 0 0
Preview
Offline: Reinvigorating One Health—merci! One lament you will often hear from global health activists is the lack of commitment, even interest, shown by high-income country political leaders towards health and health equity. There have been e...

"France's leadership could trigger the beginning of a renaissance in political commitment, partnership, and science-based decision making for health."

Richard Horton reflects on the International Summit on One Health held in Lyon earlier this month: tinyurl.com/2nht6xvy

1 day ago 5 3 1 0
Cover of The Lancet's April 18, 2026 issue. Quote on cover reads: "Platinum-resistant ovarian cancer is a leading cause of gynaecological cancer-related mortality worldwide".

Cover of The Lancet's April 18, 2026 issue. Quote on cover reads: "Platinum-resistant ovarian cancer is a leading cause of gynaecological cancer-related mortality worldwide".

Epithelial ovarian cancer frequently recurs and becomes resistant to platinum chemotherapy.

In our latest issue, two separate phase 3 trials highlight two potential new treatments for platinum-resistant ovarian cancer.

Read this & more ▶️ spkl.io/63325A4OfN

1 day ago 12 5 0 0
Panel with key takeaways from Clinical Rounds article published in The Lancet entitled 'Signe de cils in peripheral facial palsy'. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Panel with key takeaways from Clinical Rounds article published in The Lancet entitled 'Signe de cils in peripheral facial palsy'. Copyright: 2026 Elsevier Ltd. All rights are reserved.

🆕 Clinical Rounds: Signe de cils in peripheral facial palsy

🔗 spkl.io/63321A48R7

2 days ago 1 0 0 0
Post image

Celebrate 60 years of #IARCWHO research at the #IARC60 conference this May!

Who better to lead discussions on IARC’s areas of expertise than IARC’s experts?!

Explore the list of Parallel Sessions & moderators here:
iarc2026conf.iarc.who.int/en/programme...

3 days ago 2 2 0 0
Figure showing the prevalence of liver stiffness measurement (LSM; ≥8 kPa) according to the number of metabolic conditions and its association with harmful alcohol use. The numbers equate to the following: 0 is no metabolic condition; 1 is one metabolic condition; 2 is two metabolic conditions; 3 is three metabolic conditions; 4 is four metabolic conditions. The blue bars indicate no harmful alcohol use and pink bars indicate harmful alcohol use. Data show the prevalence of LSM of 8Kpa and greater and 95% CI in brackets for each condition. Odds ratios for the association between harmful alcohol use and LSM of 8 kPa and greater were calculated within each stratum of metabolic conditions, comparing participants with harmful alcohol use to those without harmful alcohol use but with the same number of metabolic conditions. The odds ratio was 1·41 in participants with no metabolic conditions, 2·97 in those with one metabolic condition, 1·79 in those with two metabolic conditions, 1·62 in those with three metabolic conditions, and 1·79 in those with four metabolic conditions. The interaction between harmful alcohol use and the number of metabolic conditions was not statistically significant, with a p value of 0·072. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Figure showing the prevalence of liver stiffness measurement (LSM; ≥8 kPa) according to the number of metabolic conditions and its association with harmful alcohol use. The numbers equate to the following: 0 is no metabolic condition; 1 is one metabolic condition; 2 is two metabolic conditions; 3 is three metabolic conditions; 4 is four metabolic conditions. The blue bars indicate no harmful alcohol use and pink bars indicate harmful alcohol use. Data show the prevalence of LSM of 8Kpa and greater and 95% CI in brackets for each condition. Odds ratios for the association between harmful alcohol use and LSM of 8 kPa and greater were calculated within each stratum of metabolic conditions, comparing participants with harmful alcohol use to those without harmful alcohol use but with the same number of metabolic conditions. The odds ratio was 1·41 in participants with no metabolic conditions, 2·97 in those with one metabolic condition, 1·79 in those with two metabolic conditions, 1·62 in those with three metabolic conditions, and 1·79 in those with four metabolic conditions. The interaction between harmful alcohol use and the number of metabolic conditions was not statistically significant, with a p value of 0·072. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Liver fibrosis is the main hallmark of chronic liver disease, progressing silently over decades and often remaining undetected.

A new study assessed the prevalence of undiagnosed liver fibrosis and its relationship with metabolic factors or alcohol consumption: spkl.io/63321ANWDf

3 days ago 5 6 0 1
The Lancet Summit: shaping the future of diabetes prevention.  Image credit: Ixefra / Getty Images

The Lancet Summit: shaping the future of diabetes prevention. Image credit: Ixefra / Getty Images

🧠 Speakers Kamlesh Khunti, Michael Bergman, Katrien Benhalima, and Anette Ziegler will highlight the latest advances in early detection and screening of #diabetes at The #LancetSummit.

Join the programme! Submit your abstract at hubs.li/Q03MV4_x0

#T1D #T2D #ADASciSessions

4 days ago 1 1 0 0
Figure showing projected prevalence (cases, in billions) and age-standardised
prevalence rates (per 100 000 people) of MASLD from 1990 to 2050
The solid lines represent GBD 2023 estimates, while the dotted lines indicate
forecasted estimates beyond 2023. The shaded areas represent 95% uncertainty
intervals. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.
MASLD=metabolic dysfunction-associated steatotic liver disease. Copyright: 2026 Elsevier Ltd. All rights reserved.

Figure showing projected prevalence (cases, in billions) and age-standardised prevalence rates (per 100 000 people) of MASLD from 1990 to 2050 The solid lines represent GBD 2023 estimates, while the dotted lines indicate forecasted estimates beyond 2023. The shaded areas represent 95% uncertainty intervals. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study. MASLD=metabolic dysfunction-associated steatotic liver disease. Copyright: 2026 Elsevier Ltd. All rights reserved.

Metabolic liver disease could affect nearly 1.8 billion people by 2050, suggests new #GBD study in @lancetgastrohep.bsky.social

Explore the research ▶️ spkl.io/63323ANwOT

4 days ago 5 5 0 0
Advertisement
Preview
Mammography should include artificial intelligence support In the past decade, deep learning has increasingly been applied to medical image interpretation, but without consensus as to whether medical practice should change. Many studies show artificial intelligence (AI) enhanced accuracy beyond the performance of radiologists. The most compelling evidence comes from the follow-up of the Mammography Screening with Artificial Intelligence (MASAI) randomised trial, which assessed the reading of two radiologists compared with one radiologist plus an AI algorithm.

Every mammogram should be supported by 3 different AIs for improved detection of cancer, prevention, and risk of heart disease. At no cost to patients.
My new @thelancet.com essay reviews the evidence and the lack of implementation
thelancet.com/journals/lan...

1 week ago 165 44 6 4
Infographic explainer for aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial

Infographic explainer for aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial

Clopidogrel vs aspirin after PCI:

10-year HOST-EXAM follow-up shows lower ischemic and bleeding events with clopidogrel—but no difference in mortality.

Read more: spkl.io/63327ANGO9 #ACC26

6 days ago 8 2 0 0
Video

Enhance your clinical knowledge today through patient case studies, graphical summaries, & more.

🩺 Visit The Lancet’s Clinical Resources hub: spkl.io/63326A2CLp

1 week ago 7 2 0 0
Human sperm and egg, conceptual artwork. Copyright: KTSDESIGN/Getty Images

Human sperm and egg, conceptual artwork. Copyright: KTSDESIGN/Getty Images

A new Editorial summarises 'The future of preconception health' tinyurl.com/y8a88vuu

1 week ago 2 0 0 0
Figure showing the pathway to impact and key actions required for local, national, and international measurement and surveillance of pregnancy planning and preconception health. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Figure showing the pathway to impact and key actions required for local, national, and international measurement and surveillance of pregnancy planning and preconception health. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Measuring progress in pregnancy planning and preconception health tinyurl.com/pva3hhy4

1 week ago 1 0 1 0
Figure showing an integrated social and biological framework for male preconception health. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Figure showing an integrated social and biological framework for male preconception health. Copyright: 2026 Elsevier Ltd. All rights are reserved.

More equitable preconception health: paternal life course opportunities for better pregnancy, child, and family outcomes tinyurl.com/4ccsx4v8

1 week ago 1 0 1 0

In 2018, a Lancet Series helped to broaden the concept of preconception health to encompass the health of women, men, & couples.

However, 8 years on, research evidence & equitable inclusion of men & male partners in policy remain inadequate.

Two new Reviews revisit this unfinished agenda ⤵️

1 week ago 2 0 1 0
Advertisement
Cover of The Lancet's April 11, 2026 issue. Quote on cover reads: "Health cannot—and should not—be overlooked in the economies of war."

Cover of The Lancet's April 11, 2026 issue. Quote on cover reads: "Health cannot—and should not—be overlooked in the economies of war."

"Every 1% increase in military spending drives a 0·62% reduction in public health spending."

On the cover, a new letter examines the relationship between military spending and public health expenditure during conflicts.

Find out more in our latest issue: spkl.io/63325ANG6W

1 week ago 32 26 1 2
Cover of the March 1 issue of The Lancet Primary Care.

Cover of the March 1 issue of The Lancet Primary Care.

New AI-themed issue of @lancetprimarycare.bsky.social 🤖

Exploring the growing role of AI in primary care—from chatbots to glaucoma screening—alongside key considerations on regulation, patient safety, and more.

spkl.io/63324A22JQ

1 week ago 5 4 0 0
Preview
Are India and China ready for a “chaotic surge” of generic obesity drugs? As patents on semaglutide expire, manufacturers are poised to introduce cheaper generic versions of blockbuster drugs, with far-reaching effects on the obesity crisis. Megan Tatum reports.

As patents on semaglutide expire, manufacturers are poised to introduce cheaper generic versions of blockbuster drugs, with far-reaching effects on the obesity crisis.

✍️ Megan Tatum reports: tinyurl.com/4fa5h7t5

1 week ago 2 1 0 0
Promotional card for the launch of the Johns Hopkins Center for Humanitarian Health–Lancet Commission on Health, Conflict, and Forced Displacement.

Promotional card for the launch of the Johns Hopkins Center for Humanitarian Health–Lancet Commission on Health, Conflict, and Forced Displacement.

Join the launch of the Johns Hopkins Center for Humanitarian Health–Lancet Commission on Health, Conflict, and Forced Displacement

📆 May 20
🕗 8:00–12:00 (GMT)
📍 Institute of Global Health, UNIGE

Find out more & register today 👉 spkl.io/63321AFlNl

1 week ago 2 2 0 0
Save the Date for the Lyon One Health Summit, 7 April 2026.

Save the Date for the Lyon One Health Summit, 7 April 2026.

🌐 One Health is on the agenda.

Join The Lancet’s Richard Horton live at the One Health Summit High-level Session.

Tomorrow, global leaders meet in Lyon & online to accelerate action—and The Lancet is part of it.

Learn more: spkl.io/63321A2ZrU

1 week ago 6 5 0 0
[18F]-fluorodeoxyglucose-PET scans in a patient with idiopathic retroperitoneal fibrosis showing a hypermetabolic tissue surrounding the lower abdominal aorta (A: axial view & C: coronal view) & the common iliac arteries (B: axial view); the left ureter is also encased (A, C, & arrows). (D, E) CT scans in a patient with idiopathic retroperitoneal fibrosis showing the typical periaorto-iliac tissue (arrows; D: coronal view & E: sagittal view). (F, G) Contrast-enhanced CT scans of the abdomen in a patient with idiopathic retroperitoneal fibrosis showing the periaortic (F: arrow) & peri-iliac (G: arrow) tissue. (H) Contrast-enhanced CT scan of the abdomen in a patient with perianeurysmal retroperitoneal fibrosis showing a soft-tissue mass (arrow) surrounding an aneurysmal aorta; the aortic lumen is partly occupied by a large thrombus. (I) Contrast-enhanced CT scan of the abdomen in a patient with retroiliac, paravertebral idiopathic retroperitoneal fibrosis (arrow; atypical localisation).

[18F]-fluorodeoxyglucose-PET scans in a patient with idiopathic retroperitoneal fibrosis showing a hypermetabolic tissue surrounding the lower abdominal aorta (A: axial view & C: coronal view) & the common iliac arteries (B: axial view); the left ureter is also encased (A, C, & arrows). (D, E) CT scans in a patient with idiopathic retroperitoneal fibrosis showing the typical periaorto-iliac tissue (arrows; D: coronal view & E: sagittal view). (F, G) Contrast-enhanced CT scans of the abdomen in a patient with idiopathic retroperitoneal fibrosis showing the periaortic (F: arrow) & peri-iliac (G: arrow) tissue. (H) Contrast-enhanced CT scan of the abdomen in a patient with perianeurysmal retroperitoneal fibrosis showing a soft-tissue mass (arrow) surrounding an aneurysmal aorta; the aortic lumen is partly occupied by a large thrombus. (I) Contrast-enhanced CT scan of the abdomen in a patient with retroiliac, paravertebral idiopathic retroperitoneal fibrosis (arrow; atypical localisation).

Retroperitoneal fibrosis is a rare immune-mediated disease which can be classified as idiopathic or secondary.

A new Seminar provides an overview of retroperitoneal fibrosis focusing on pathophysiology, differential diagnosis, and management: spkl.io/63323AFbdz

1 week ago 4 1 0 0
Figure illustrating the effect of pyruvate kinase activators on cellular mechanisms that influence cell survival. Figure created using biorender.com. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Figure illustrating the effect of pyruvate kinase activators on cellular mechanisms that influence cell survival. Figure created using biorender.com. Copyright: 2026 Elsevier Ltd. All rights are reserved.

Hereditary haemolytic anaemias represent the most prevalent group of genetic disorders worldwide.

A Therapeutics paper provides a comprehensive overview of pyruvate kinase activators as a novel therapeutic approach for hereditary haemolytic anaemias: spkl.io/63325AFnmc

1 week ago 6 2 0 0
Advertisement
Global map of age-standardised childhood cancer incidence rates in 2023, for all sexes combined. Copyright: 2026 Elsevier Ltd. All rights reserved.

Global map of age-standardised childhood cancer incidence rates in 2023, for all sexes combined. Copyright: 2026 Elsevier Ltd. All rights reserved.

Information on childhood cancer burden is crucial for effective cancer policy planning.

A new #GBD study analysed the global burden of cancer in children and adolescents aged 0–19 years.

Explore the findings ➡️ spkl.io/63324AFnco IHME_UW

1 week ago 9 4 0 0
Cover of The Lancet's April 4, 2026 issue. Quote on cover reads: "The tools to cure most childhood cancers are already available. Achieving equitable outcomes now depends on delivering effective treatments to all children, not just to those in the wealthiest countries."

Cover of The Lancet's April 4, 2026 issue. Quote on cover reads: "The tools to cure most childhood cancers are already available. Achieving equitable outcomes now depends on delivering effective treatments to all children, not just to those in the wealthiest countries."

On the cover, our latest Editorial—'Childhood cancer: progress, but not enough'

Read this & more in our latest issue ▶️ spkl.io/63328AF70M

2 weeks ago 12 7 1 1
Promotional card announcing the launch of The Lancet Regional Health - Eastern Mediterranean. Text on card reads: Discover a new open access journal advancing clinical practice and health policy in the Eastern Mediterranean. Image depicts a woman sitting in a chair while speaking to a doctor holding an electronic tablet.

Promotional card announcing the launch of The Lancet Regional Health - Eastern Mediterranean. Text on card reads: Discover a new open access journal advancing clinical practice and health policy in the Eastern Mediterranean. Image depicts a woman sitting in a chair while speaking to a doctor holding an electronic tablet.

🆕 Introducing The Lancet Regional Health – Eastern Mediterranean, a new #goldopenaccess journal promoting the advancement of clinical practice and health policy in the Eastern Mediterranean.

Discover the new addition to The Lancet Group at: spkl.io/63328AFIyw #medsky

2 weeks ago 3 7 0 0

🏷️ @ucberkeleyissi.bsky.social @publichealth.berkeley.edu

2 weeks ago 1 0 0 0
Promotional card for an event entitled Social Forces/Clinical cases - Breaking boundaries with The Lancet's Cases in Global Social Medicine and Michael Marmot. The event is taking place on 16th April 2026 at 4.30pm - 6.30pm PT at Goldman Theater, David Brower Center, Berkeley. Image is a headshot of Michael Marmot.

Promotional card for an event entitled Social Forces/Clinical cases - Breaking boundaries with The Lancet's Cases in Global Social Medicine and Michael Marmot. The event is taking place on 16th April 2026 at 4.30pm - 6.30pm PT at Goldman Theater, David Brower Center, Berkeley. Image is a headshot of Michael Marmot.

On April 16, join experts as they discuss a series of Cases in Global Social Medicine published in The Lancet.

The cases centre real clinical cases from around the world that together form a practical social medicine toolkit.

Register to attend ➡️ spkl.io/63323AF9xb

2 weeks ago 2 2 1 0
Pattern of blisters with colorful pills and capsules on beige background. Copyright: Tanja Ivanova via Getty Images.

Pattern of blisters with colorful pills and capsules on beige background. Copyright: Tanja Ivanova via Getty Images.

Launched in 2025, Africa's new medicines regulator, the African Medicines Agency, is working to win the support of countries to meet its extensive agenda.

✍️ Andrew Green reports: spkl.io/63321AF9ID

2 weeks ago 2 1 0 0